Anxiety Disorder, Cervical Cancer, Endometrial Cancer, Female Reproductive Cancer, Gestational Trophoblastic Tumor, Ovarian Epithelial Cancer, Ovarian Germ Cell Tumor, Sexual Dysfunction, Uterine Sarcoma, Vaginal Cancer, Vulvar Cancer
Conditions
Brief summary
This randomized pilot clinical trial studies the feasibility of a pre-operative and/or post-operative scripted sexual health informational intervention and how well it works in improving sexual function in patients with gynecologic cancer. Discussing sexual outcomes and counseling options with patients may help improve sexual outcomes and/or anxiety after primary gynecologic cancer treatment.
Detailed description
PRIMARY OBJECTIVES: I. To evaluate the feasibility of patient recruitment, including time required to consent, enroll and retain the necessary number of participants. II. To determine the distribution of candidate primary patient-reported outcome measures, including time to resumption of sexual activity, global satisfaction with sex life, sexual function and anxiety in this particular population. III. To establish the prevalence of patient recall of the intervention to determine the most effective time at which to deliver the intervention. OUTLINE: Patients are randomized to 1 of 4 treatment arms. ARM I: Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit. ARM II: Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit. ARM III: Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit. ARM IV: Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.
Interventions
OTHERinformational intervention
Given scripted intervention
OTHERcounseling intervention
Given standard counseling
OTHERquestionnaire administration
Ancillary studies
Sponsors
National Cancer Institute (NCI)
University of Wisconsin, Madison
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with a new suspected or confirmed gynecologic malignancies * Patients plan to have primary surgery at either the University of Chicago Hospital or the University of Wisconsin Hospital * Patients must be English speaking
Exclusion criteria
* Previous treatment of any cancer excluding skin cancer * Patients with a suspected benign gynecologic process * Patients who are prisoners or incarcerated
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of patient recruitment | Up to 9 months | To inform possible issues in recruitment for a large-scale randomized controlled trial, the ratio of enrolled subjects to total eligible potential subjects as well as the time necessary to recruit those subjects will be tracked. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Retention | Up to 9 months | The percentage of subjects completing the final assessment from the total number of subjects enrolled will be calculated. |
| Satisfaction with sex life independent of specific sexual function measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global Satisfaction with Sex Life questionnaire | Up to 9 months | Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms. |
| PROMIS Sexual Function Profile | Up to 9 months | Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms. |
| Resumption of sexual activity after cancer surgery | Up to 9 months | Resumption of sexual activity after cancer surgery will be measured using items adapted from a previous national, multi-site study of sexual outcomes following an acute myocardial infarction. |
| Patient-reported anxiety measured by PROMIS Anxiety 4a short form | Up to 6 months | Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms. |
| Rate of referral acceptance | Up to 9 months | The rate of acceptance of sexual health clinic referrals as well as rates of utilization of these referrals will be tracked using medical record abstraction. |
| Recall of intervention | Up to 9 months | Subjects will be queried to learn whether they recall receiving physician counseling about sexual health outcomes after surgery with follow up questions regarding whether or not the patient has spoken with other healthcare providers about sexual concerns. |
Countries
United States
Outcome results
None listed